IP Library › Assignment 024855/0213
Patent Assignment
Reel/Frame 024855/0213

Change of Name

Recorded: 2010-08-18 Pages: 4
Assignor
MYRIAD PHARMACEUTICALS, INC.
Executed: 2010-07-01
Assignee
MYREXIS, INC.
305 CHIPETA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property (1)
Compounds and Therapeutical Use Thereof
Patent: 8,309,562 →
Application: 12/500,863 →
Publication: US 2010/0069383
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 6, 2009
From: ANDERSON, MARK B.; WILLARDSEN, J. ADAM; WEINER, WARREN S.; YUNGAI, ASHANTAI
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023484/0145 →
Security Agreement Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →
Release of Security Interest Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →